Log in
Enquire now
QTERN

QTERN

(dapagliflozin and saxagliptin)

OverviewStructured DataIssuesContributors

Contents

astrazeneca-us.com...ns.html
den8dhaj6zs0e.cloudfront.net..._v.pdf
Is a
Product
Product

Product attributes

Industry
Pharmaceutical and Medicine Manufacturing
Pharmaceutical and Medicine Manufacturing
Product Parent Company
AstraZeneca
AstraZeneca

QTERN is indicated as an adjunct to diet and exercise to improve glycemic control in adults

with type 2 diabetes mellitus.

Limitations of Use

QTERN is not recommended for patients with type 1 diabetes mellitus. It may increase the risk

of diabetic ketoacidosis in these patients [see WARNINGS AND PRECAUTIONS.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like QTERN

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.